Alejandra López‐Ibáñez de Aldecoa

The cost‐effectiveness of isavuconazole compared to voriconazole, the standard of care in the treatment of patients with invasive mould diseases, prior to differential pathogen diagnosis in Spain

José Ramón Azanza Perea, Santiago Grau, Lourdes Vázquez et al. · Mycoses · 2020 · 16 citations · Full text

Pharmacy, Infectious Diseases, Pharmacoeconomics +17

Cost-effectiveness Analysis of Maternal Immunization with RSVpreF Vaccine for the Prevention of Respiratory Syncytial Virus Among Infants in Spain

Javier Álvarez Aldeán, Irene Rivero‐Calle, Rosa Rodríguez Fernández et al. · Infectious Diseases and Therapy · 2024 · 16 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacoeconomics +17

Cost-utility analysis of the use of the 20-valent anti-pneumococcal vaccine (PCV20) in adults older than 60 years in Spain

David Cantarero, Daniel Ocaña, Maria Ángeles Onieva-García et al. · Vaccine · 2023 · 15 citations · Full text

Pharmacy, Infectious Diseases, Pharmacoeconomics +17

Health and economic impact of the correct diagnosis of transthyretin cardiac amyloidosis in Spain

Francesç Formiga, Pablo García‐Pavía, Francisco Javier Martín‐Sánchez et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2021 · 13 citations · Full text

Pharmacy, Cardiology, Pharmacoeconomics +17